Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.380
0.00 (0.00%)
At close: Sep 10, 2025, 4:00 PM
2.430
+0.050 (2.10%)
Pre-market: Sep 11, 2025, 4:00 AM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $161.28 million as of September 11, 2025. Its market cap has decreased by -59.92% in one year.
Market Cap
161.28M
Enterprise Value
-25.49M
1-Year Change
-59.92%
Ranking
Category
Stock Price
2.38
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $161.28M, a decrease of -60.00%. That is a compound annual growth rate of -20.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 161.28M | 33.29% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.10B |
| Johnson & Johnson | 429.00B |
| AbbVie | 370.61B |
| UnitedHealth Group | 290.04B |
| AstraZeneca | 251.37B |
| Novartis AG | 249.66B |
| Novo Nordisk | 242.52B |
| Abbott Laboratories | 230.09B |